Takeda Pharmaceutical
286 hedge funds and large institutions have $753M invested in Takeda Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 69 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 48
28% less capital invested
Capital invested by funds: $1.04B → $753M (-$290M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
286
Holding in Top 10
1
Calls
$36.6M
Puts
$6.22M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$12.1M | |
| 3 | +$9.04M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.53M |
| 5 |
Goldman Sachs
New York
|
+$7.3M |
Top Sellers
| 1 | -$111M | |
| 2 | -$107M | |
| 3 | -$21.4M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$13.7M |
| 5 |
HT
HAP Trading
New York
|
-$10.8M |